Taking stock: Provider prescribing practices in the presence and absence of ACT stock

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Hensen, Bernadette ^a   Paintain, Lucy ^a   Shretta, Rima ^b   Bruce, Jane ^a   Jones, Caroline ^a   Webster, Jayne ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Center for Pharmaceutical Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE;

ALTERNATIVE MEDICINE; CLINICAL PRACTICE; HEALTH CARE FACILITY; HEALTH SURVEY; HUMAN; KENYA; MALARIA; MEDICAL LITERATURE; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SYSTEMATIC REVIEW; UGANDA; ZAMBIA; AFRICA; ARTICLE; DRUG COMBINATION; HEALTH CARE PERSONNEL; META ANALYSIS; METHODOLOGY; STATISTICS;

AFRICA; ANTIMALARIALS; ARTEMISININS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; HEALTH PERSONNEL; HUMANS; LACTONES; MALARIA; QUININE;

EID: 79961000627     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-218     Document Type: Review

References (33)

1. Malaria eradication back on the table. Tanner M, De Savigny D, Bull World Health Organ 2008 86 82 83 10.2471/BLT.07.050633 18297155 (Pubitemid 351213705)
2. Decreased availability of anti-malarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Hetzel M, Msechu J, Goodman C, Lengeler C, Obrist B, Kachur SP, Makemba A, Nathan R, Schulze A, Mshinda H, Malar J 2006 5 109 10.1186/1475-2875-5-109 17105662 (Pubitemid 44790513)
3. RBM, Global Strategic Plan: Roll Back Malaria 2005-2015 Geneva: Roll Back Malaria 2005
4. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC, J Infect Dis 1993 167 932 937 10.1093/infdis/167.4.932 8450258 (Pubitemid 23088265)
5. WHO, World Malaria Report 2008 Geneva: World Health Organization 2008
6. Health worker performance in the management of paediatric fevers following in-service training and exposure to job aids in Kenya. Wasunna BZ, Bruce J, Jones C, Webster J, Snow R, Malar J 2010 9 261 20849650
7. WHO, World Malaria Report 2009 Geneva: World Health Organization 2009
8. RBM, Roll Back Malaria Progress & Impact Series: World Malaria Day 2010 Africa Update: Roll Back Malaria 2010
9. WHO, Guidelines for treatment of malaria Geneva: World Health Organization 2 2010
10. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. Mosha JF, Conteh L, Tediosi F, Gesase S, Bruce J, Chandramohan D, Gosling R, PLoS ONE 2010 5 8707 10.1371/journal.pone.0008707 20090933
11. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Bosman A, Mendis KN, Am J Trop Med Hyg 2007 77 193 197 18165492
12. Time for a "Third Wave" of malaria activism to tackle the drug stock-out crisis. PLoS Med 2009 6 1000188 19936043
13. The effect of distance from home on attendance at a small rural health centre in Papua New Guinea. Muller I, Smith T, Mellor S, Rare L, Genton B, Int J Epidemiol 1998 27 878 884 10.1093/ije/27.5.878 9839747 (Pubitemid 28504978)
14. Memusi D, Mbithi A, Nyandigisi A, Shieshia M, Muturi A, Zurovac D, Juma E, Monitoring outpatient malaria case management under the 2010 diagnostic and treatment policy in Kenya. Baseline Results Division of Malaria Control Ministry of Public Health & Sanitation 2010
15. Improved diagnostic testing and malaria treatment practices in Zambia. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, Sipilinyambe N, Simon JL, Snow RW, JAMA 2007 297 2227 2231 10.1001/jama.297.20.2227 17519412 (Pubitemid 47010880)
16. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW, BMJ 2005 331 734 10.1136/bmj.331.7519.734 16195289
17. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW, Malar J 2007 6 31 10.1186/1475-2875-6-31 17367518 (Pubitemid 46482315)
18. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW, Malar J 2008 7 181 10.1186/1475-2875-7-181 18803833
19. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW, Trop Med Int Health 2008 13 99 107 10.1111/j.1365-3156. 2007.01980.x 18291008 (Pubitemid 351271396)
20. APPMG, The Control of Malaria 2005-15:progress and priorities towards Eradication. The Sixth Report of the All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases(APPMG) 2010
21. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW, Malar J 2007 6 72 10.1186/1475-2875-6-72 17535417 (Pubitemid 46919082)
22. From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Sipilanyambe N, Simon JL, Chanda P, Olumese P, Snow RW, Hamer DH, Malar J 2008 7 25 10.1186/1475-2875-7-25 18230140 (Pubitemid 351302473)
23. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin- combination therapy. Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D, Malar J 2009 8 2 10.1186/1475-2875-8-2 19123926
24. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS, Malekela DA, East Afr J Public Health 2007 4 43 46 17907761
25. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Wasunna B, Zurovac D, Goodman CA, Snow RW, Malar J 2008 7 29 10.1186/1475-2875-7-29 18252000 (Pubitemid 351389088)
26. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. Whitty CCCAE, Leslie T, Staedke S, Malar J 2008 7 Suppl 1 7 10.1186/1475-2875-7-S1-S7 19091041
27. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW, Malar J 2007 6 72 10.1186/1475-2875-6-72 17535417 (Pubitemid 46919082)
28. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. Mulligan JA, Mandike R, Palmer N, Williams H, Abdulla S, Bloland P, Mills A, Trop Med Int Health 2006 11 452 461 10.1111/j.1365-3156.2006.01590.x 16553928
29. Quality of treatment for febrile illness among children at outpatient facilities in sub-Saharan Africa. Zurovac D, Rowe AK, Ann Trop Med Parasitol 2006 100 283 296 10.1179/136485906X105633 16762109 (Pubitemid 46952619)
30. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Chandler CI, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ, Malar J 2008 7 53 10.1186/1475-2875-7-53 18384669 (Pubitemid 351551369)
31. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, Whitty CJ, BMJ 2007 334 403 10.1136/bmj.39073.496829.AE 17259188 (Pubitemid 46374647)
32. Determinants of provider choice for malaria treatment: experiences from The Gambia. Wiseman V, Scott A, Conteh L, McElroy B, Stevens W, Soc Sci Med 2008 67 487 496 10.1016/j.socscimed.2008.04.007 18538458
33. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Chuma J, Okungu V, Molyneux C, Malar J 2010 9 144 10.1186/1475-2875-9-144 20507555